HIF1A and pulmonary arterial hypertension: Overall, our findings revealed HSP90AA1, HIF1A, MET, IGF1, LRRK2, CLTC, DNM1L, MDM2, RICTOR, and ROCK2 as potential diagnostic biomarkers and therapeutic targets for PAH.